M Shibuya1, T Asano, Y Sasaki. Show Affiliations » 1. Chukyo Hospital, Nagoya, Tokyo, Japan.
Abstract
Entities: Chemical Disease
Mesh: See more » 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/administration & dosage1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/analogs & derivatives1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/therapeutic useAnimalsEnzyme Inhibitors/administration & dosageEnzyme Inhibitors/therapeutic useHumansInjections, Intra-ArterialProtein Kinase InhibitorsVasospasm, Intracranial/drug therapy
Substances: See more » Enzyme InhibitorsProtein Kinase Inhibitors1-(5-Isoquinolinesulfonyl)-2-Methylpiperazinefasudil
Year: 2001 PMID: 11563286 DOI: 10.1007/978-3-7091-6232-3_42
Source DB: PubMed Journal: Acta Neurochir Suppl ISSN: 0065-1419